Use of liraglutide or semaglutide therapy does not increase risk for thyroid cancer among patients with type 2 diabetes or obesity.

Maternal oral corticosteroid use during pregnancy is not associated with a substantially increased risk for gestational diabetes.

The Food and Drug Administration has approved Nereus (tradipitant) for the prevention of vomiting induced by motion in adults.

Semaglutide use was linked to lower rates of hospitalization in adults with established cardiovascular disease and higher BMI.

The US Centers for Disease Control and Prevention reported the highest number of measles cases in decades amid decreasing vaccination rates.

Individuals with UC who discontinue 5-aminosalicylates have an increased risk for relapse compared with those who maintain treatment.